Equity (Tables)

9 Months Ended

Sep. 30, 2021

Equity Method Investments and Joint Ventures [Abstract]

Summary of warrants outstanding

	Shares of Common Stock Issuable from Warrants Outstanding as of			Weighted
	September 30,	December 31,		Average
Description	2021	2020		Exercise Price	Expiration
Series E	-	584,416	$	1.54	September 9, 2021
Series F	7,246	7,246	$	3.45	February 23, 2022 & March 9, 2022
Series G	460,250	460,250	$	2.68	July 21, 2022
Series H	910,000	910,000	$	2.75	October 16, 2022
Series I	10,335,000	10,335,000	$	2.00	November 26, 2025
Total	11,712,496	12,296,912

Summary of stock option activity

	Number of Options			Weighted Average Exercise Price ($)		Weighted Average Remaining Contractual Term (years)		Aggregate Intrinsic Value ($)
Outstanding at December 31, 2020		5,895,570			2.45		5.14		1,650
Granted		50,000			1.72		9.82		-
Forfeited		(2,805,571	)		2.74
Outstanding at September 30, 2021		3,139,999			2.17		4.79		1,650
Vested and exercisable at September 30, 2021		2,564,999			1.95		4.73		1,650

Summary of assumption of stock option activity

	Nine Months Ended September 30,
	2021			2020
Risk-free interest rate		0.73	%		0.021%	–	1.67%
Expected term in years		5.38			3.25	–	6.00
Weighted Avg. Expected Volatility		102.07			103.56%	–	110.71%
Expected dividend yield		0	%			0%

Summary of consolidated statement of operations

	Three Months Ended September 30,				Nine Months Ended September 30,
	2021		2020		2021			2020
Research and development	$	224,000	$	455,271	$	731,438		$	1,087,147
General and administrative		44,000		664,544		(1,138,601	)		2,084,953
Total	$	268,000	$	1,119,815	$	(407,163	)	$	3,172,100